Suchergebnisse

Pelagic sharks are an important bycatch in pelagic fisheries, especially for drifting longlines targeting swordfish. In the Cabo Verde Archipelago (tropical NE Atlantic), pelagic shark catches can reach a significant proportion of the total catches. Due to the increased concern on the status of pelagic shark species, this study was developed to enhance the current knowledge of those sharks in the Cabo Verde region in comparison to the adjacent areas, especially associated with European Union (EU) pelagic longline fishing activity. Stock status indicators for the two main species, blue shark (Prionace glauca) and shortfin mako (Isurus oxyrinchus), were developed, based on fisheries data from logbooks and onboard scientific observers, including analysis of size frequency distributions and standardized catch-per-unit-of-effort (CPUE) indexes over time. The standardized CPUEs have been stable or increasing for both species in the past 10 years, indicating no signs of local depletion. In terms of sizes, the blue shark catch is composed mainly of adults, which can be a sign of a stable population. On the contrary, the catch of shortfin mako is composed mainly of juveniles, which in conjunction of a decrease of mean size might be a cause of concern, highlighting possible overfishing on the species in the region. Thirty satellite tags, 25 archival miniPATs and 5 SPOT GPS, were deployed in the Cabo Verde Exclusive Economic Zone (EEZ), showing that those species are highly mobile. The biomass and size distributions were modeled with spatial and seasonal models (GAMs) identifying locations where juveniles are predominantly concentrated and that should be prioritized for conservation. This work presents new information on the status of pelagic sharks in the Cabo Verde region in the context of those highly migratory species, and can now be used to promote more sustainable fisheries in the region. ; 1

We thank A.R. Green for advice and support; M. García-Fernández, C. Fielding, C. Kapeni, X. Langa, and other current and former members of the S.M.-F. group for help and discussions; A. Barettino and A. Macías (CNIC), D. Pask, T. Hamilton, the Central Biomedical Services and Cambridge NIHR BRC Cell Phenotyping Hub for technical assistance; and H. Jolin and A.N.J. McZenzie (MRC Laboratory of Molecular Biology, Cambridge, UK) for help with milliplex analyses. Y.-H.O. received fellowships from Alborada Scholarship (University of Cambridge), Trinity-Henry Barlow Scholarship (University of Cambridge), and R.O.C. Government Scholarship to Study Abroad (GSSA). A.G.G. received fellowships from the Ramón Areces Foundation and the LaCaixa Foundation. C.K. was supported by Marie Curie Career Integration (H2020-MSCA-IF-2015-70841). S.M.-F. was supported by Red TerCel (ISCIII-Spanish Cell Therapy Network). V.A. is supported by grants from the Spanish Ministerio de Economía, Industria y Competitividad (MEIC) with cofunding from the Fondo Europeo de Desarrollo Regional (FEDER, ''Una manera de hacer Europa'') (SAF2016-79490-R), the Instituto de Salud Carlos III (AC16/00091 and AC17/00067), the Fundació Marató TV3 (122/C/2015), and the Progeria Research Foundation (Established Investigator Award 2014–52). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia, Innovación y Universidades (MCIU), and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). This work was supported by core support grants from the Wellcome Trust and the MRC to the Cambridge Stem Cell Institute, MEIC (SAF-2011-30308), Ramón y Cajal Program Grant (RYC-2009-04703), ConSEPOC-Comunidad de Madrid (S2010/ BMD-2542), National Health Service Blood and Transplant (United Kingdom), European Union's Horizon 2020 research (ERC-2014-CoG-64765 and Marie Curie Career Integration grant FP7-PEOPLE-2011-RG-294096), and a Programme Foundation Award from Cancer Research UK to S.M.-F., who was also ...